Covered recipient · General Payments record
ERIC HOWELL
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$5,015.21
- Reported across 217 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $535.95 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $286.83 | 19 |
| LEO Pharma Inc. | $128.24 | 8 |
| GENZYME CORPORATION | $37.15 | 2 |
| Lilly USA, LLC | $32.77 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.04 | 1 |
| Janssen Biotech, Inc. | $15.78 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.75 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944149 | CMS |
| ABBVIE INC. | $13.99 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944151 | CMS |
| ABBVIE INC. | $13.24 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944153 | CMS |
| ABBVIE INC. | $5.30 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944155 | CMS |
| ABBVIE INC. | $18.34 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944157 | CMS |
| ABBVIE INC. | $7.17 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944159 | CMS |
| ABBVIE INC. | $13.48 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944161 | CMS |
| ABBVIE INC. | $28.49 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944163 | CMS |
| ABBVIE INC. | $13.61 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944165 | CMS |
| ABBVIE INC. | $9.21 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944167 | CMS |
| ABBVIE INC. | $13.90 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944169 | CMS |
| ABBVIE INC. | $18.59 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944171 | CMS |
| ABBVIE INC. | $19.55 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944173 | CMS |
| ABBVIE INC. | $19.82 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944175 | CMS |
| ABBVIE INC. | $26.31 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944177 | CMS |
| ABBVIE INC. | $11.40 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944179 | CMS |
| ABBVIE INC. | $16.40 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944181 | CMS |
| ABBVIE INC. | $12.47 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944183 | CMS |
| ABBVIE INC. | $11.81 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103944185 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.14 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101800376 | CMS |
| GENZYME CORPORATION | $17.70 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139938601 | CMS |
| GENZYME CORPORATION | $19.45 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139938693 | CMS |
| Janssen Biotech, Inc. | $15.78 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078832769 | CMS |
| LEO Pharma Inc. | $17.16 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152635049 | CMS |
| LEO Pharma Inc. | $19.76 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152635051 | CMS |
| LEO Pharma Inc. | $19.15 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152635053 | CMS |
| LEO Pharma Inc. | $15.92 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152635055 | CMS |
| LEO Pharma Inc. | $14.07 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152635057 | CMS |
| LEO Pharma Inc. | $14.07 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152635059 | CMS |
| LEO Pharma Inc. | $13.68 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152635061 | CMS |
| LEO Pharma Inc. | $14.43 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152635063 | CMS |
| Lilly USA, LLC | $14.39 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134973755 | CMS |
| Lilly USA, LLC | $18.38 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134973421 | CMS |
| Novartis Pharmaceuticals Corporation | $20.04 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086957157 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.